Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Aquestive Therapeutics, Inc. (AQST) had Free Cash Flow per Share of $-0.41 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$57.56M |
|
$-44.14M |
|
$17.87M |
|
$39.69M |
|
$88.33M |
|
$-30.77M |
|
$-13.38M |
|
$-44.15M |
|
$-44.15M |
|
$-44.14M |
|
$-44.14M |
|
$-44.14M |
|
$-44.14M |
|
$-30.77M |
|
$-19.34M |
|
86.73M |
|
86.73M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$88.22M |
|
$3.80M |
|
$13.20M |
|
$101.42M |
|
$18.86M |
|
$32.50M |
|
$142.72M |
|
$161.58M |
|
$-60.16M |
|
$-60.16M |
|
$-60.16M |
|
91.41M |
|
| Cash Flow Statement Financials | |
$-35.76M |
|
$-0.16M |
|
$83.59M |
|
$23.87M |
|
$71.55M |
|
$47.67M |
|
$7.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.68 |
|
-- |
|
-- |
|
-1.18 |
|
-0.54 |
|
68.95% |
|
-53.46% |
|
-53.46% |
|
-33.60% |
|
-76.70% |
|
-76.68% |
|
$-35.92M |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
2.96 |
|
7.84 |
|
46.57 |
|
73.37% |
|
73.37% |
|
-43.52% |
|
159.59% |
|
$-0.66 |
|
|
Free Cash Flow per Share |
$-0.41 |
$-0.41 |
|